Autopsy report · NCT00665418
Sevoflurane and Laryngeal Reflex Responses in Pediatric Patients
Cause of deathSlow enrollment
“Recruitment finished earlier, because all 40 patients enrolled”
Life of this trial
- Ran for about 6 months before it stopped.
- 40 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- University Hospital, Basel, Switzerland
- Sponsor type
- University, hospital or other
- Conditions
- Laryngospasm
- Interventions
- sevoflurane
- Participants
- 40
Trials that died the same way
- TPF Followed by Cetuximab and IMRT Plus Carbon Ion Boost for Locally Advanced Head and Neck Tumors
“slow recruitment (only 8 patients recruited and treated until 12/2012)” - Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency
“study was stopped after enrolment of about 200 patients for slow recruitment” - Propofol and Dexmedetomidin vs Midazolam Intraoperative Sedation and POCD
“Too long recruitment period due to small number of patients” - Rituximab in Metastatic Melanoma
“the only reason is that recruitment was not sufficient to meet the planned patient numbers, because complete remissions are still infrequent.” - Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults
“No more patients complying the selection criteria were available for recruitment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.